Hepatic lesions observed in hepatitis c virus transgenic mice infected by helicobacter hepaticus

Helicobacter

Volumn 18, Issue 1, 2013, Pages 33-40

  Le Roux Goglin, Emilie ^a,b   Dubus, Pierre ^a   Asencio, Corinne ^a,b   Jutand, Marthe Aline ^b   Rosenbaum, Jean ^a,b   Mégraud, Francis ^a,b  

^a Bordeaux Institute of Oncology   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

Adenoma; Carcinoma; Focal cellular alteration; Genetic susceptibility; Hepatitis; Mortality; Steatosis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BODY WEIGHT; CONTROLLED STUDY; DISEASE ASSOCIATION; FATTY LIVER; FEMALE; GENETIC SUSCEPTIBILITY; GENOTYPE; HELICOBACTER HEPATICUS; HELICOBACTER INFECTION; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; INFECTION SENSITIVITY; LIVER ADENOMA; LIVER INJURY; LIVER WEIGHT; MALE; MIXED INFECTION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TRANSGENIC MOUSE;

ANIMALS; COINFECTION; DISEASE MODELS, ANIMAL; FOLLOW-UP STUDIES; HELICOBACTER HEPATICUS; HELICOBACTER INFECTIONS; HEPACIVIRUS; HEPATITIS C; LIVER; MALE; MICE; MICE, TRANSGENIC;

HELICOBACTER; HELICOBACTER HEPATICUS; HEPATITIS C VIRUS; MUS; MUS MUSCULUS;

EID: 84872403067     PISSN: 10834389     EISSN: 15235378     Source Type: Journal    
DOI: 10.1111/j.1523-5378.2012.00995.x     Document Type: Article

References (25)

1. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Hepatitis Viruses. Lyon, France: IARC, 1994;59:1-255.
2. Ward JM, Fox JG, Anver MR, Haines DC, George CV, Collins MJ Jr, Gorelick PL, Nagashima K, Gonda MA, Gilden RV. Chronic active hepatitis and associated liver tumors in mice caused by a persistent bacterial infection with a novel Helicobacter species. J Natl Cancer Inst 1994;86:1222-7.
3. IARC Monograph on the Evaluation of Carcinogenic Risks to Humans. Schistosomes, Liver Flukes and Helicobacter pylori. Lyon, France: IARC, 1994;61:177-240.
4. Pellicano R, Menard A, Rizzetto M, Megraud F. Helicobacter species and liver diseases: association or causation? Lancet Infect Dis 2008;8:254-60.
5. Dore MP, Realdi G, Mura D, Graham DY, Sepulveda AR. Helicobacter infection in patients with HCV-related chronic hepatitis, cirrhosis, and hepatocellular carcinoma. Dig Dis Sci 2002;47:1638-43.
6. Rocha M, Avenaud P, Menard A, Le Bail B, Balabaud C, Bioulac-Sage P, de Magalhaes Queiroz DM, Mégraud F. Association of Helicobacter species with hepatitis C cirrhosis with or without hepatocellular carcinoma. Gut 2005;54:396-401.
7. Fox JG, Feng Y, Theve EJ, et al. Gut microbes define liver cancer risk in mice exposed to chemical and viral transgenic hepatocarcinogens. Gut 2010;59:88-97.
8. Ward JM, Anver MR, Haines DC, Benveniste RE. Chronic active hepatitis in mice caused by Helicobacter hepaticus. Am J Pathol 1994;145:959-68.
9. Keasler VV, Lerat H, Madden CR, et al. Increased liver pathology in hepatitis C virus transgenic mice expressing the hepatitis B virus X protein. Virology 2006;347:466-75.
10. Garcia A, Ihrig MM, Fry RC, Feng Y, Xu S, Boutin SR, Rogers AB, Muthupalani S, Samson LD, Fox JG. Genetic susceptibility to chronic hepatitis is inherited codominantly in Helicobacter hepaticus-infected AB6F1 and B6AF1 hybrid male mice, and progression to hepatocellular carcinoma is linked to hepatic expression of lipogenic genes and immune function-associated networks. Infect Immun 2008;76:1866-76.
11. Suerbaum S, Josenhans C, Sterzenbach T, et al. The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci USA 2003;100:7901-6.
12. Lerat H, Honda M, Beard MR, et al. Steatosis and liver cancer in transgenic mice expressing the structural and nonstructural proteins of hepatitis C virus. Gastroenterology 2002;122:352-65.
13. Fox JG, Dewhirst FE, Shen Z, et al. Hepatic Helicobacter species identified in bile and gallbladder tissue from Chileans with chronic cholecystitis. Gastroenterology 1998;114:755-63.
14. Mohr U, ed. International Classification of Rodent Tumors. The Mouse. Berlin, New York, Springer-Verlarg Heidelberg, 2001;474.
15. Rogers AB, Theve EJ, Feng Y, Fry RC, Taghizadeh K, Clapp KM, Boussahmain C, Cormier KS, Fox JG. Hepatocellular carcinoma associated with liver-gender disruption in male mice. Cancer Res 2007;67:11536-46.
16. Takahashi M, Dinse GE, Foley JF, Hardisty JF, Maronpot RR. Comparative prevalence, multiplicity, and progression of spontaneous and vinyl carbamate-induced liver lesions in five strains of male mice. Toxicol Pathol 2002;30:599-605.
17. Dragani TA, Manenti G, Gariboldi M, De Gregorio L, Pierotti MA. Genetics of liver tumor susceptibility in mice. Toxicol Lett 1995;83:613-9.
18. Fenton PF, Dowling MT. Studies on obesity. I. Nutritional obesity in mice. J Nutr 1953;49:319-31.
19. Maggio-Price L, Bielefeldt-Ohmann H, Treuting P, Iritani BM, Zeng W, Nicks A, Tsang M, Shows D, Morrissey P, Viney JL. Dual infection with Helicobacter bilis and Helicobacter hepaticus in p-glycoprotein-deficient mdr1a-/- mice results in colitis that progresses to dysplasia. Am J Pathol 2005;166:1793-806.
20. Myles MH, Dieckgraefe BK, Criley JM, Franklin CL. Characterization of cecal gene expression in a differentially susceptible mouse model of bacterial-induced inflammatory bowel disease. Inflamm Bowel Dis 2007;13:822-36.
21. Whary MT, Morgan TJ, Dangler CA, Gaudes KJ, Taylor NS, Fox JG. Chronic active hepatitis induced by Helicobacter hepaticus in the A/JCr mouse is associated with a Th1 cell-mediated immune response. Infect Immun 1998;66:3142-8.
22. Kuehl CJ, Wood HD, Marsh TL, Schmidt TM, Young VB. Colonization of the cecal mucosa by Helicobacter hepaticus impacts the diversity of the indigenous microbiota. Infect Immun 2005;73:6952-61.
23. Rao VP, Poutahidis T, Ge Z, Nambiar PR, Boussahmain C, Wang YY, Horwitz BH, Fox JG, Erdman SE. Innate immune inflammatory response against enteric bacteria Helicobacter hepaticus induces mammary adenocarcinoma in mice. Cancer Res 2006;66:7395-400.
24. Pratt JS, Sachen KL, Wood HD, Eaton KA, Young VB. Modulation of host immune responses by the cytolethal distending toxin of Helicobacter hepaticus. Infect Immun 2006;74:4496-504.
25. Ge Z, Sterzenbach T, Whary MT, et al. Helicobacter hepaticus HHGI1 is a pathogenicity island associated with typhlocolitis in B6.129-IL10 tm1Cgn mice. Microbes Infect 2008;10:726-33.